Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 7;22(7):748.
doi: 10.3390/e22070748.

Multi-scale Entropy Evaluates the Proarrhythmic Condition of Persistent Atrial Fibrillation Patients Predicting Early Failure of Electrical Cardioversion

Affiliations

Multi-scale Entropy Evaluates the Proarrhythmic Condition of Persistent Atrial Fibrillation Patients Predicting Early Failure of Electrical Cardioversion

Eva María Cirugeda Roldan et al. Entropy (Basel). .

Abstract

Atrial fibrillation (AF) is nowadays the most common cardiac arrhythmia, being associated with an increase in cardiovascular mortality and morbidity. When AF lasts for more than seven days, it is classified as persistent AF and external interventions are required for its termination. A well-established alternative for that purpose is electrical cardioversion (ECV). While ECV is able to initially restore sinus rhythm (SR) in more than 90% of patients, rates of AF recurrence as high as 20-30% have been found after only a few weeks of follow-up. Hence, new methods for evaluating the proarrhythmic condition of a patient before the intervention can serve as efficient predictors about the high risk of early failure of ECV, thus facilitating optimal management of AF patients. Among the wide variety of predictors that have been proposed to date, those based on estimating organization of the fibrillatory (f-) waves from the surface electrocardiogram (ECG) have reported very promising results. However, the existing methods are based on traditional entropy measures, which only assess a single time scale and often are unable to fully characterize the dynamics generated by highly complex systems, such as the heart during AF. The present work then explores whether a multi-scale entropy (MSE) analysis of the f-waves may provide early prediction of AF recurrence after ECV. In addition to the common MSE, two improved versions have also been analyzed, composite MSE (CMSE) and refined MSE (RMSE). When analyzing 70 patients under ECV, of which 31 maintained SR and 39 relapsed to AF after a four week follow-up, the three methods provided similar performance. However, RMSE reported a slightly better discriminant ability of 86%, thus improving the other multi-scale-based outcomes by 3-9% and other previously proposed predictors of ECV by 15-30%. This outcome suggests that investigation of dynamics at large time scales yields novel insights about the underlying complex processes generating f-waves, which could provide individual proarrhythmic condition estimation, thus improving preoperative predictions of ECV early failure.

Keywords: atrial fibrillation; composite multiscale entropy; electrical cardioversion; electrocardiogram; multiscale entropy; refined multiscale entropy; sample entropy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Example of a common electrocardiogram (ECG) segment (a), along with the extracted f-waves (b) by average QRST complex subtraction.
Figure 2
Figure 2
Boxplot distributions of the parameters previously proposed in the literature to predict ECV outcome, i.e., (a) f-waves amplitude (FWA), (b) normalized f-waves amplitude (nFWA) (c) dominant frequency (DF), and (d) Sample Entropy (SE). The central mark indicates the median, the bottom and top edges of the box indicate the 25th and 75th percentiles, respectively, and the whiskers extend to the most extreme data points not considered outliers. The outliers are plotted using the symbol +.
Figure 3
Figure 3
Median values (symbol ◼) and interquartile ranges (whiskers) of (a) multi-scale entropy (MSE), (b) composite MSE (CMSE) and (c) refined MSE (RMSE) as a function of the time scale (τ) for patients maintaining SR and relapsing to AF at the end of the follow-up.
Figure 4
Figure 4
Boxplot distributions of AHS and SHS for (a) MSE, (b) CMSE, and (c) RMSE. The central mark indicates the median, the bottom and top edges of the box indicate the 25th and 75th percentiles, respectively, and the whiskers extend to the most extreme data points not considered outliers.
Figure 5
Figure 5
ROC curves for SE obtained from the best time scale, AHS and SHS derived from (a) MSE, (b) CMSE, (c) RMSE. The point marks optimal threshold according to the Youden’s criterion.

References

    1. Lippi G., Sanchis-Gomar F., Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int. J. Stroke. 2020:1747493019897870. doi: 10.1177/1747493019897870. - DOI - PubMed
    1. Lane D.A., Skjøth F., Lip G.Y.H., Larsen T.B., Kotecha D. Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care. J. Am. Heart Assoc. 2017;6:e005155. doi: 10.1161/JAHA.116.005155. - DOI - PMC - PubMed
    1. Duarte R.C.F., Rios D.R.A., Figueiredo E.L., Caiaffa J.R.S., Silveira F.R., Lanna R., Alves L.C.V., Martins G.L., Reis H.J., Reis E.A., et al. Thrombin Generation and other hemostatic parameters in patients with atrial fibrillation in use of warfarin or rivaroxaban. J. Thromb. Thrombolysis. 2020 doi: 10.1007/s11239-020-02126-3. - DOI - PubMed
    1. Khoo C.W., Krishnamoorthy S., Lim H.S., Lip G.Y.H. Atrial fibrillation, arrhythmia burden and thrombogenesis. Int. J. Cardiol. 2012;157:318–323. doi: 10.1016/j.ijcard.2011.06.088. - DOI - PubMed
    1. Zoni-Berisso M., Lercari F., Carazza T., Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clin. Epidemiol. 2014;6:213–220. doi: 10.2147/CLEP.S47385. - DOI - PMC - PubMed